IDFC goes up post the call-off of merger with Shriram Group: 31 Oct 2017

With the long-talked merger between IDFC and Shriram Group being called off, it was expected that the shares would catch the downtrend. However, the company broke the perception, gaining by over 1.5% in the early trading hours of Tuesday. The mergers between the two companies were called off on basis of differences over valuations. "This is to inform you that despite best efforts, IDFC Group and Shriram Group have not been able to reach common ground on a mutually acceptable swap ratio," IDFC said in a note to the stock exchanges after the market closed on Monday. As per the merger plan, Shriram City Union Finance was to merge with IDFC...

Read More

Capitalstars Updates:Gap down open seen on D-Street; SGX Nifty down 10 pts: 31 Oct 2017

Indian Indices: Indian benchmark indices are likely to open lower on Tuesday, tracking bearish cues from Nifty futures on the Singapore Stock Exchange and weak trend across global peers. Markets across Asia were trading lower following the weak closing of the Wall Street in overnight trade. SGX Nifty is trading at 10390 down by 10 points. Equity benchmark ended at record closing highs led by index heavyweights like Reliance industries and Hdfc bank. Sensex closed up by 109 points at 33266 and Nifty closed up by 40 points at 10364. It was a day of broader markets as the Midcap and Smallcap indices rallied more than 1%. Global Market: ...

Read More

Capitalstars Updates: OPENING BELL: 31 Oct 2017

NIFTY SPOT DOWN 10@ 10352 SENSEX DOWN 35@33232 BANK NIFTY FUTURES UP 15 @25080 CS NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES2:10525 RES 1:10405 SUP1:10375 SUP2:10275 CS BANK NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES 2:25325 RES 1:25275 SUP1:24915 SUP2: 24825 Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us.  Also u can visit :- capitalstars Quick payment  capitalstars past performance Get more details...

Read More

PSU banks snap 2-day losing run on short covering: 30 Oct 2017

Shares of public sector banks rose on the further covering of short positions by traders after the recent surge in the stocks on the announcement of government's Rs 2.11 trillion recapitalization plan. Nifty PSU Bank was up 2% at around 11:35 AM today. Shares of Union Bank of India, Syndicate Bank, Oriental Bank of Commerce, Punjab National Bank, Canara Bank, State Bank of India, and Andhra Bank were up 2-7%. Union Bank of India is currently trading at Rs 185.8, up by Rs 10.25 or 5.84% from its previous closing of Rs 175.55 on the BSE. The scrip opened at Rs 175 and has touched a high and low of Rs 191.5 and Rs 172.95 respectively....

Read More

Capitalstars Updates: Mkts to open higher; SGX Nifty up 45 pts: 30 Oct 2017

Indian Indices: Indian benchmark indices are likely to open higher on Monday, tracking bullish cues from Nifty futures on the Singapore Stock Exchange and firm trend across global peers. Nifty HDFC and Tata Steel Q2 to remain in focus today. SGX Nifty is trading up 45 points. Indian Indexes soared to life-time high in opening trade as the November derivatives series took off on a strong footing amid positive Asian cues Auto sales data, Quarterly earnings, macroeconomic data points and recapitalization play are going to be the crucial metrics this week. Global Market: • US stock markets hit new peaks on Friday after forecast-beating...

Read More

Capitalstars Updates: OPENING BELL: 30 Oct 2017

NIFTY SPOT UP 42 @10362 SENSEX UP 117 @33275 BANK NIFTY FUTURES UP 67 @25050 CS NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES2:10525 RES 1:10405 SUP1:10275 SUP2:10175 CS BANK NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES 2:25325 RES 1:25225 SUP1:24925 SUP2: 24825 Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us.  Also u can visit :- capitalstars Quick payment  capitalstars past performance Get more details...

Read More

Tata Metaliks Limited net zooms 54%: 28 Oct 2017

Tata Metaliks Limited (TML), which makes ductile iron water pipes, has reported a 54% year-on-year increase in quarterly net profit, helped by higher sales and lower input cost.  For the quarter ended September 30, net profit increased to Rs 33.5 crore from Rs 21.73 crore a year ago, the company said on Friday. Its revenue stood at Rs 450 crore compared with Rs 342.85 crore in the same quarter of FY17, as pig iron sales jumped 30% on a sequential basis over the first quarter of the current fiscal, mainly on account of firming up of prices in August and September.  TML also reaped the benefit of improved cost efficiencies...

Read More

Indiabulls Housing settles case with SEBI: 28 Oct 2017

Indiabulls Housing Finance has settled a case pertaining to shareholding disclosure lapse with the Securities and Exchange Board of India after paying Rs 14.4 lakh towards settlement fees.  Indiabulls Employee Welfare Trust was holding more than 1 percent in Indiabulls Housing Finance (earlier known as Indiabulls FinancialBSE 2.85 % Services), for the quarters ended December 2010 until June 2012.  However, Indiabulls Housing had allegedly failed to disclose the shareholding of Indiabulls Employee Welfare Trust to both NSE and BSE under the category of public shareholders holding more than 1 percent of the company's...

Read More

Cipla’s US subsidiary receives final approval for generic Renvela Tablets: 27 Oct 2017

Cipla’s US subsidiary, InvaGen Pharmaceuticals Inc. (collectively Cipla), has received final approval for its Abbreviated New Drug Application (ANDA) for Sevelamer Carbonate tablets, 800 mg, from the USFDA to market a generic version of Genzyme’s Renvela tablets, 800 mg. Renvela tablets, 800 mg of Genzyme Corporation and are indicated for the control of serum phosphorus in adults with chronic kidney disease (CKD) on dialysis. This approval is positive for the company as this is the niche product which could improve its market share in the US and hence it is expected to improve its US revenues. Renvela tablets had US sales...

Read More

Capitalstars Updates: Gap up opening seen on D-Street; SGX Nifty up 13 pts: 27 Oct 2017

Indian Indices: Indian benchmark indices are likely to start November series F&O expiry on positive note, tracking bullish cues from Nifty futures on the Singapore Stock Exchange and firm trend across global peers. SGX Nifty is trading @10387, +13 points. Equity benchmarks as well as Midcap index continued to end at record closing high on Thursday, with the Nifty rallying 6 % in October series (the highest ever gains in a series in 2017). Global Market: • U.S. stocks closed higher on Thursday as the latest set of earnings reports gave investors a positive surprise. • Asian shares gained on Friday as technology shares were...

Read More

Capitalstars Updates: OPENING BELL: 27 Oct 2017

NIFTY SPOT UP 15@10360 SENSEX UP 92 @33242 BANK NIFTY FUTURES DOWN 84@24995 CS NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES2:10525 RES 1:10405 SUP1:10275 SUP2:10175 CS BANK NIFTY FUTURES (NOV) OVERVIEW TREND BULLISH RES 2:25325 RES 1:25225 SUP1:24975 SUP2: 24825 Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide a free trial to our client.Join our services and trade with us.  Also u can visit :- capitalstars Quick payment  capitalstars past performance Get more details...

Read More

Pharma stocks up; Cipla, Cadila among gainers: 26 Oct 2017

Shares of GlaxoSmithKline Pharmaceuticals BSE 2.87 % (up 2.86 percent), Cipla BSE 2.56 % (up 2.23 percent), Cadila Healthcare BSE 1.18 % (up 1.47 percent), Piramal Enterprises (up 0.68 percent) and Sun Pharmaceutical Industries BSE 0.61 % (up 0.62 percent) were gaining in Thursday's trade.  The Nifty Pharma index was trading 0.57 per cent up at 9,399 around 11:05 am (IST). Benchmark NSE Nifty50 index was 7 points down at 10,289, while the BSE Sensex was 70 points at 32,972.  Dr. Reddy's Laboratories BSE -1.13 % (down 1.07 percent), Divi's Laboratories BSE -0.55 % (down 0.48 percent) and Lupin BSE -0.63 % (down 0.34 percent)...

Read More